Skip to main content
. 2019 Apr 2;19:72. doi: 10.1186/s12890-019-0838-2

Fig. 1.

Fig. 1

Inclusion and exclusion flow diagram. NSCLC, non-small cell cancer; ILD, interstitial lung disease; Bev, bevacizumab; CDDP, cisplatin; PEM, pemetrexed; CBDCA, carboplatin; PTX, paclitaxel; DTX, docetaxel; VNR, vinorelbine